Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Mycbp2em1flox/Cya
Common Name:
Mycbp2-flox
Product ID:
S-CKO-00467
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mycbp2-flox
Strain ID
CKOCMP-105689-Mycbp2-B6J-VA
Gene Name
Mycbp2
Product ID
S-CKO-00467
Gene Alias
C130061D10Rik; Pam; Phr1
Background
C57BL/6JCya
NCBI ID
105689
Modification
Conditional knockout
Chromosome
14
Phenotype
MGI:2179432
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Mycbp2em1flox/Cya mice (Catalog S-CKO-00467) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000159855
NCBI RefSeq
NM_207215
Target Region
Exon 4
Size of Effective Region
~1.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
MYCBP2, also known as PAM or Phr1, is an atypical really interesting new gene (RING) ubiquitin ligase and signalling hub. It is involved in diverse processes such as neuronal connectivity, synaptic growth, cell division, neuronal survival, and protein ubiquitination. It participates in pathways related to axon development, immune response regulation, and lipid metabolism, and is of great biological importance [1,4,5]. Genetic models like Caenorhabditis elegans are valuable for studying MYCBP2.

Loss-of-function variants in MYCBP2 in patients lead to neurobehavioural phenotypes and corpus callosum defects. Nuclease technology-mediated introduction of disease-associated variants into the C. elegans MYCBP2 orthologue, RPM-1, showed axonal and behavioural abnormalities, suggesting MYCBP2 variants likely result in loss of function [1]. In spinal cord injury, MYCBP2 delivered via ginsenoside Rg1-pretreated neuronal cell-derived extracellular vesicles promotes microglial M2-phenotype polarization and reduces oxidative stress, thus enhancing neurological recovery [2]. In thyroid cancer, high MYCBP2 expression is associated with increased infiltration of immune cells, better prognosis, and higher sensitivity to immunotherapy, suggesting it may be a predictive biomarker for immune checkpoint inhibitor efficacy [3]. In MASH-associated hepatocellular carcinoma, MYCBP2 acts as a potential tumor suppressor by modulating lipid metabolism through promoting the ubiquitination and degradation of HNF4α [4]. In breast cancer, dysregulation of MYCBP2 is accompanied by decreased disease-free survival, and its loss confers resistance to apoptosis from cisplatin-induced DNA damage [6].

In conclusion, MYCBP2 is crucial for normal biological functions, especially in neural development, immune response, and cancer-related processes. Studies using model organisms and patient-derived data have revealed its role in various disease conditions, including neurodevelopmental disorders, spinal cord injury, thyroid cancer, hepatocellular carcinoma, and breast cancer. These findings provide insights into potential therapeutic targets related to MYCBP2-associated pathways.

References:
1. AlAbdi, Lama, Desbois, Muriel, Rusnac, Domniţa-Valeria, Grill, Brock, Alkuraya, Fowzan S. . Loss-of-function variants in MYCBP2 cause neurobehavioural phenotypes and corpus callosum defects. In Brain : a journal of neurology, 146, 1373-1387. doi:10.1093/brain/awac364. https://pubmed.ncbi.nlm.nih.gov/36200388/
2. Rong, Yuluo, Wang, Jiaxing, Hu, Tao, Zhang, Feng, Zhang, Wenzhi. 2024. Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell-Derived Extracellular Vesicles. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2402114. doi:10.1002/advs.202402114. https://pubmed.ncbi.nlm.nih.gov/38896802/
3. Wang, Guilin, Miao, Chen, Mo, Lijun, Pang, Weiyi, Shi, Wenjie. 2022. MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients. In Frontiers in immunology, 13, 1048503. doi:10.3389/fimmu.2022.1048503. https://pubmed.ncbi.nlm.nih.gov/36582246/
4. Zhang, Hao, Kong, Xiangxu, Qu, Haoran, Zhai, Xiangyu, Jin, Bin. 2025. MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma. In Oncogene, , . doi:10.1038/s41388-025-03373-5. https://pubmed.ncbi.nlm.nih.gov/40181155/
5. Chang, Chao, Banerjee, Sara L, Park, Sung Soon, Grill, Brock, Kania, Artur. 2024. Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function. In eLife, 12, . doi:10.7554/eLife.89176. https://pubmed.ncbi.nlm.nih.gov/38289221/
6. Neff, Ryan A, Bosch-Gutierrez, Almudena, Sun, Yifei, Walsh, Martin J, Zhang, Bin. 2023. Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers. In NAR cancer, 5, zcad036. doi:10.1093/narcan/zcad036. https://pubmed.ncbi.nlm.nih.gov/37435531/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest